Insider Trades188 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Sell | ISRG | David J. Rosa | Chief Executive Officer (CEO) | 947 | $411.55 | $122.3B | -42.80% | +0.25% | $389.7K | -0.37% | — | Trim |
| Jun 11, 2026 | Sell | ISRG | Mark Brosius | EVP & Chief Mfg and Supply Cha | 48 | $413.19 | $122.3B | -42.80% | +0.25% | $19.8K | -1.66% | 10b5-1 | Trim |
| Jun 10, 2026 | Sell | ISRG | Gary Loeb | EVP & Chief Legal and Complian | 400 | $424.14 | $122.3B | -42.80% | +0.25% | $169.7K | -6.54% | 10b5-1 | Trim |
| Jun 10, 2026 | Sell | ISRG | David J. Rosa | Chief Executive Officer (CEO) | 674 | $426.61 | $122.3B | -42.80% | +0.25% | $287.5K | -0.27% | — | Trim |
| Jun 8, 2026 | Sell | ISRG | Mark Brosius | EVP & Chief Mfg and Supply Cha | 69 | $421.80 | $122.3B | -42.80% | +0.25% | $29.1K | -1.53% | 10b5-1 | Trim |
| Jun 1, 2026 | Sell | ISRG | Iman Jeddi | SVP & GM da Vinci Platforms & | 11,250 | $248.77 | $122.3B | -42.80% | +0.25% | $2.8M | +0.00% | 10b5-1 | Trim |
| May 21, 2026 | Sell | ISRG | Mark Brosius | EVP & Chief Mfg and Supply Cha | 36 | $442.92 | $122.3B | -42.80% | +0.25% | $15.9K | -1.16% | 10b5-1 | Trim |
| May 18, 2026 | Sell | ISRG | Mark Brosius | EVP & Chief Mfg and Supply Cha | 54 | $434.52 | $122.3B | -42.80% | +0.25% | $23.5K | -1.13% | 10b5-1 | Trim |
| May 11, 2026 | Sell | ISRG | Gary Loeb | EVP & Chief Legal and Complian | 400 | $446.95 | $122.3B | -42.80% | +0.25% | $178.8K | -6.13% | 10b5-1 | Trim |
| Mar 10, 2026 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 210 | $361.67 | $122.3B | -42.80% | +0.25% | $76.0K | +0.00% | 10b5-1 | Trim |
| Mar 6, 2026 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 1,293 | $487.61 | $122.3B | -42.80% | +0.25% | $630.5K | -25.04% | 10b5-1 | Trim |
| Mar 3, 2026 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 3,658 | $496.19 | $122.3B | -42.80% | +0.25% | $1.8M | -22.81% | 10b5-1 | Trim |
| Mar 2, 2026 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 4,978 | $480.33 | $122.3B | -42.80% | +0.25% | $2.4M | -30.43% | 10b5-1 | Trim |
| Feb 28, 2026 | Sell | ISRG | Gary Loeb | EVP & Chief Legal and Complian | 1,562 | $503.51 | $122.3B | -42.80% | +0.25% | $786.5K | -19.33% | — | Trim |
| Feb 28, 2026 | Sell | ISRG | Iman Jeddi | SVP & GM da Vinci Platforms & | 4,466 | $503.51 | $122.3B | -42.80% | +0.25% | $2.2M | -33.91% | — | Trim |
| Feb 28, 2026 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 4,590 | $503.51 | $122.3B | -42.80% | +0.25% | $2.3M | -34.01% | — | Trim |
| Feb 28, 2026 | Sell | ISRG | Henry L Charlton | EVP & Chief Commercial and Mkt | 5,135 | $503.51 | $122.3B | -42.80% | +0.25% | $2.6M | -22.94% | — | Trim |
| Feb 28, 2026 | Sell | ISRG | Jamie Samath | EVP & CFO & Enterprise Technol | 5,716 | $503.51 | $122.3B | -42.80% | +0.25% | $2.9M | -18.43% | — | Trim |
| Feb 28, 2026 | Sell | ISRG | David J. Rosa | Chief Executive Officer (CEO) | 12,357 | $503.51 | $122.3B | -42.80% | +0.25% | $6.2M | -1.69% | — | Trim |
| Feb 27, 2026 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 600 | $498.72 | $122.3B | -42.80% | +0.25% | $299.2K | -16.31% | 10b5-1 | Trim |
| Feb 27, 2026 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 6,997 | $502.24 | $122.3B | -42.80% | +0.25% | $3.5M | -52.00% | 10b5-1 | Trim |
| Feb 26, 2026 | Sell | ISRG | Patricia L Wadors | SVP Chief Human Resources Offi | 458 | $503.07 | $122.3B | -42.80% | +0.25% | $230.4K | -8.13% | 10b5-1 | Trim |
| Feb 26, 2026 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 491 | $506.17 | $122.3B | -42.80% | +0.25% | $248.5K | -7.44% | — | Trim |
| Feb 26, 2026 | Sell | ISRG | Iman Jeddi | SVP & GM da Vinci Platforms & | 972 | $506.17 | $122.3B | -42.80% | +0.25% | $492.0K | -4.30% | — | Trim |
| Feb 26, 2026 | Sell | ISRG | Gary Loeb | EVP & Chief Legal and Complian | 1,212 | $506.17 | $122.3B | -42.80% | +0.25% | $613.5K | -5.24% | — | Trim |
| Feb 26, 2026 | Sell | ISRG | Henry L Charlton | EVP & Chief Commercial and Mkt | 1,224 | $506.17 | $122.3B | -42.80% | +0.25% | $619.6K | -3.78% | — | Trim |
| Feb 26, 2026 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 1,288 | $506.17 | $122.3B | -42.80% | +0.25% | $651.9K | -5.35% | — | Trim |
| Feb 26, 2026 | Sell | ISRG | Jamie Samath | EVP & CFO & Enterprise Technol | 1,638 | $506.17 | $122.3B | -42.80% | +0.25% | $829.1K | -3.58% | — | Trim |
| Feb 26, 2026 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 2,309 | $506.17 | $122.3B | -42.80% | +0.25% | $1.2M | -12.52% | — | Trim |
| Feb 26, 2026 | Sell | ISRG | David J. Rosa | Chief Executive Officer (CEO) | 3,027 | $506.17 | $122.3B | -42.80% | +0.25% | $1.5M | -0.58% | — | Trim |
| Feb 10, 2026 | Sell | ISRG | Gary Loeb | EVP & Chief Legal and Complian | 172 | $492.84 | $122.3B | -42.80% | +0.25% | $84.8K | -4.11% | — | Trim |
| Feb 10, 2026 | Sell | ISRG | Iman Jeddi | SVP & GM da Vinci Platforms & | 309 | $492.84 | $122.3B | -42.80% | +0.25% | $152.3K | -17.84% | — | Trim |
| Feb 10, 2026 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 433 | $492.84 | $122.3B | -42.80% | +0.25% | $213.4K | -23.24% | — | Trim |
| Feb 10, 2026 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 435 | $493.49 | $122.3B | -42.80% | +0.25% | $214.7K | -17.72% | 10b5-1 | Trim |
| Feb 10, 2026 | Sell | ISRG | Henry L Charlton | EVP & Chief Commercial and Mkt | 492 | $492.84 | $122.3B | -42.80% | +0.25% | $242.5K | -9.34% | — | Trim |
| Feb 10, 2026 | Sell | ISRG | Jamie Samath | EVP & CFO & Enterprise Technol | 496 | $492.84 | $122.3B | -42.80% | +0.25% | $244.4K | -5.29% | — | Trim |
| Feb 10, 2026 | Sell | ISRG | David J. Rosa | Chief Executive Officer (CEO) | 724 | $492.84 | $122.3B | -42.80% | +0.25% | $356.8K | -0.31% | — | Trim |
| Feb 10, 2026 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 1,048 | $467.48 | $122.3B | -42.80% | +0.25% | $489.9K | -14.11% | 10b5-1 | Trim |
| Jan 29, 2026 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 252 | $364.46 | $122.3B | -42.80% | +0.25% | $91.8K | +0.00% | 10b5-1 | Trim |
| Jan 27, 2026 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 460 | $375.43 | $122.3B | -42.80% | +0.25% | $172.7K | +0.00% | 10b5-1 | Trim |
| Dec 15, 2025 | Sell | ISRG | Mark Brosius | — | 464 | $548.49 | $122.3B | -42.80% | +0.25% | $254.5K | -77.98% | 10b5-1 | Trim |
| Dec 12, 2025 | Sell | ISRG | Mark Brosius | — | 312 | $547.36 | $122.3B | -42.80% | +0.25% | $170.8K | -34.40% | 10b5-1 | Trim |
| Dec 12, 2025 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 9,464 | $325.02 | $122.3B | -42.80% | +0.25% | $3.1M | -6.43% | 10b5-1 | Trim |
| Dec 10, 2025 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 208 | $394.65 | $122.3B | -42.80% | +0.25% | $82.1K | +0.00% | 10b5-1 | Trim |
| Dec 1, 2025 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 250 | $388.94 | $122.3B | -42.80% | +0.25% | $97.2K | +0.00% | 10b5-1 | Trim |
| Dec 1, 2025 | Buy | ISRG | Gary S Guthart | Executive Chair of the Board o | 48,306 | $343.18 | $122.3B | -42.80% | +0.25% | $16.6M | +10.56% | 10b5-1 | Trim |
| Nov 12, 2025 | Sell | ISRG | Henry L Charlton | EVP & Chief Commercial and Mkt | 22,731 | $441.40 | $122.3B | -42.80% | +0.25% | $10.0M | -5.84% | 10b5-1 | Trim |
| Nov 10, 2025 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 210 | $394.69 | $122.3B | -42.80% | +0.25% | $82.9K | +0.00% | 10b5-1 | Trim |
| Nov 10, 2025 | Sell | ISRG | Brian Edward Miller | EVP & Chief Digital Officer | 7,000 | $395.75 | $122.3B | -42.80% | +0.25% | $2.8M | +0.00% | 10b5-1 | Trim |
| Nov 5, 2025 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 4,134 | $312.82 | $122.3B | -42.80% | +0.25% | $1.3M | +0.00% | 10b5-1 | Trim |
| Nov 3, 2025 | Sell | ISRG | David J. Rosa | Chief Executive Officer (CEO) | 5,454 | $544.21 | $122.3B | -42.80% | +0.25% | $3.0M | -2.33% | — | Trim |
| Oct 28, 2025 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 15,374 | $391.09 | $122.3B | -42.80% | +0.25% | $6.0M | +0.00% | 10b5-1 | Trim |
| Oct 24, 2025 | Buy | ISRG | David J. Rosa | Chief Executive Officer (CEO) | 51,500 | $302.24 | $122.3B | -42.80% | +0.25% | $15.6M | +0.51% | 10b5-1 | Trim |
| Oct 24, 2025 | Buy | ISRG | Gary S Guthart | Executive Chair of the Board o | 67,600 | $314.21 | $122.3B | -42.80% | +0.25% | $21.2M | +3.90% | 10b5-1 | Trim |
| Oct 10, 2025 | Sell | ISRG | Gary Loeb | EVP & Chief Legal and Complian | 1,296 | $443.76 | $122.3B | -42.80% | +0.25% | $575.1K | -17.35% | — | Trim |
| Aug 29, 2025 | Buy | ISRG | Gary S Guthart | Executive Chair of the Board o | 65,360 | $256.11 | $122.3B | -42.80% | +0.25% | $16.7M | +10.65% | 10b5-1 | Trim |
| Jul 28, 2025 | Sell | ISRG | Gary S Guthart | Executive Chair of the Board o | 29,086 | $199.13 | $122.3B | -42.80% | +0.25% | $5.8M | -1.03% | 10b5-1 | Trim |
| Jul 25, 2025 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 9,000 | $367.41 | $122.3B | -42.80% | +0.25% | $3.3M | +0.00% | 10b5-1 | Trim |
| Jun 10, 2025 | Sell | ISRG | David J. Rosa | President | 674 | $526.15 | $122.3B | -42.80% | +0.25% | $354.6K | -0.29% | — | Trim |
| Jun 5, 2025 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 431 | $561.91 | $122.3B | -42.80% | +0.25% | $242.2K | -17.51% | 10b5-1 | Trim |
| Jun 4, 2025 | Sell | ISRG | David J. Rosa | President | 851 | $557.95 | $122.3B | -42.80% | +0.25% | $474.8K | -0.37% | — | Trim |
| Jun 2, 2025 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 645 | $550.60 | $122.3B | -42.80% | +0.25% | $355.1K | -12.16% | 10b5-1 | Trim |
| May 15, 2025 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 42 | $561.81 | $122.3B | -42.80% | +0.25% | $23.6K | -1.04% | 10b5-1 | Trim |
| May 12, 2025 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 66 | $558.88 | $122.3B | -42.80% | +0.25% | $36.9K | -1.06% | 10b5-1 | Trim |
| May 2, 2025 | Sell | ISRG | Jamie Samath | — | 1,830 | $393.93 | $122.3B | -42.80% | +0.25% | $720.9K | +0.00% | 10b5-1 | Trim |
| Apr 25, 2025 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 1,980 | $383.72 | $122.3B | -42.80% | +0.25% | $759.8K | +0.00% | 10b5-1 | Trim |
| Apr 25, 2025 | Sell | ISRG | Gary Loeb | EVP & Chief Legal and Complian | 1,700 | $513.18 | $122.3B | -42.80% | +0.25% | $872.4K | -43.09% | 10b5-1 | Trim |
| Apr 25, 2025 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 8,000 | $377.76 | $122.3B | -42.80% | +0.25% | $3.0M | +0.00% | 10b5-1 | Trim |
| Mar 13, 2025 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 14,826 | $448.88 | $122.3B | -42.80% | +0.25% | $6.7M | -4.16% | 10b5-1 | Trim |
| Mar 11, 2025 | Sell | ISRG | Brian Edward Miller | EVP & Chief Digital Officer | 18,734 | $399.24 | $122.3B | -42.80% | +0.25% | $7.5M | -8.26% | 10b5-1 | Trim |
| Mar 7, 2025 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 489 | $533.18 | $122.3B | -42.80% | +0.25% | $260.7K | -18.95% | 10b5-1 | Trim |
| Mar 5, 2025 | Buy | ISRG | David J. Rosa | President | 45,759 | $244.76 | $122.3B | -42.80% | +0.25% | $11.2M | +1.39% | 10b5-1 | Trim |
| Mar 4, 2025 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 1,476 | $558.94 | $122.3B | -42.80% | +0.25% | $825.0K | -13.80% | 10b5-1 | Trim |
| Feb 28, 2025 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 1,043 | $571.54 | $122.3B | -42.80% | +0.25% | $596.1K | -31.93% | 10b5-1 | Trim |
| Feb 28, 2025 | Sell | ISRG | Henry L Charlton | EVP & Chief Commercial and Mkt | 2,020 | $563.77 | $122.3B | -42.80% | +0.25% | $1.1M | -10.09% | — | Trim |
| Feb 28, 2025 | Sell | ISRG | Jamie Samath | EVP & CFO & Enterprise Technol | 2,614 | $541.40 | $122.3B | -42.80% | +0.25% | $1.4M | -4.45% | 10b5-1 | Trim |
| Feb 28, 2025 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 3,102 | $565.36 | $122.3B | -42.80% | +0.25% | $1.8M | -16.07% | 10b5-1 | Trim |
| Feb 28, 2025 | Sell | ISRG | Brian Edward Miller | EVP & Chief Digital Officer | 3,358 | $563.77 | $122.3B | -42.80% | +0.25% | $1.9M | -10.20% | — | Trim |
| Feb 28, 2025 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 3,553 | $563.77 | $122.3B | -42.80% | +0.25% | $2.0M | -10.15% | — | Trim |
| Feb 28, 2025 | Sell | ISRG | David J. Rosa | President | 4,475 | $563.77 | $122.3B | -42.80% | +0.25% | $2.5M | -1.00% | — | Trim |
| Feb 28, 2025 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 6,014 | $570.59 | $122.3B | -42.80% | +0.25% | $3.4M | -36.18% | 10b5-1 | Trim |
| Feb 28, 2025 | Sell | ISRG | Gary S Guthart | CEO | 7,456 | $563.77 | $122.3B | -42.80% | +0.25% | $4.2M | -17.52% | — | Trim |
| Feb 26, 2025 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 604 | $573.74 | $122.3B | -42.80% | +0.25% | $346.5K | -10.53% | — | Trim |
| Feb 26, 2025 | Sell | ISRG | Gary Loeb | EVP & Chief Legal and Complian | 758 | $573.74 | $122.3B | -42.80% | +0.25% | $434.9K | -5.86% | — | Trim |
| Feb 26, 2025 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 1,226 | $573.74 | $122.3B | -42.80% | +0.25% | $703.4K | -5.86% | — | Trim |
| Feb 26, 2025 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 1,229 | $573.74 | $122.3B | -42.80% | +0.25% | $705.1K | -9.21% | — | Trim |
| Feb 26, 2025 | Sell | ISRG | Henry L Charlton | EVP & Chief Commercial and Mkt | 1,343 | $573.74 | $122.3B | -42.80% | +0.25% | $770.5K | -6.55% | — | Trim |
| Feb 26, 2025 | Sell | ISRG | Brian Edward Miller | EVP & Chief Digital Officer | 1,622 | $573.74 | $122.3B | -42.80% | +0.25% | $930.6K | -5.95% | — | Trim |
| Feb 26, 2025 | Sell | ISRG | Jamie Samath | EVP & CFO & Enterprise Technol | 1,797 | $556.90 | $122.3B | -42.80% | +0.25% | $1.0M | -3.79% | 10b5-1 | Trim |
| Feb 26, 2025 | Sell | ISRG | David J. Rosa | President | 2,740 | $573.74 | $122.3B | -42.80% | +0.25% | $1.6M | -0.61% | — | Trim |
| Feb 26, 2025 | Sell | ISRG | Gary S Guthart | CEO | 3,963 | $573.74 | $122.3B | -42.80% | +0.25% | $2.3M | -9.60% | — | Trim |
| Feb 26, 2025 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 4,763 | $577.40 | $122.3B | -42.80% | +0.25% | $2.8M | -28.36% | 10b5-1 | Trim |
| Feb 12, 2025 | Sell | ISRG | Gary Loeb | EVP & Chief Legal and Complian | 5,200 | $385.17 | $122.3B | -42.80% | +0.25% | $2.0M | +0.00% | 10b5-1 | Trim |
| Feb 10, 2025 | Sell | ISRG | Gary Loeb | EVP & Chief Legal and Complian | 169 | $582.98 | $122.3B | -42.80% | +0.25% | $98.5K | -4.25% | — | Trim |
| Feb 10, 2025 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 298 | $582.98 | $122.3B | -42.80% | +0.25% | $173.7K | -15.96% | — | Trim |
| Feb 10, 2025 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 388 | $582.98 | $122.3B | -42.80% | +0.25% | $226.2K | -4.60% | — | Trim |
| Feb 10, 2025 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 430 | $582.98 | $122.3B | -42.80% | +0.25% | $250.7K | -15.61% | — | Trim |
| Feb 10, 2025 | Sell | ISRG | Henry L Charlton | EVP & Chief Commercial and Mkt | 492 | $582.98 | $122.3B | -42.80% | +0.25% | $286.8K | -7.82% | — | Trim |
| Feb 10, 2025 | Sell | ISRG | Brian Edward Miller | EVP & Chief Digital Officer | 669 | $582.98 | $122.3B | -42.80% | +0.25% | $390.0K | -6.04% | — | Trim |
| Feb 10, 2025 | Sell | ISRG | David J. Rosa | President | 723 | $582.98 | $122.3B | -42.80% | +0.25% | $421.5K | -0.34% | — | Trim |
| Feb 10, 2025 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 838 | $586.28 | $122.3B | -42.80% | +0.25% | $491.3K | -23.10% | 10b5-1 | Trim |
| Feb 10, 2025 | Sell | ISRG | Jamie Samath | EVP & CFO & Enterprise Technol | 1,019 | $501.39 | $122.3B | -42.80% | +0.25% | $510.9K | -1.87% | 10b5-1 | Trim |
| Feb 10, 2025 | Sell | ISRG | Gary S Guthart | CEO | 1,055 | $582.98 | $122.3B | -42.80% | +0.25% | $615.0K | -13.35% | — | Trim |
| Jan 28, 2025 | Sell | ISRG | Jamie Samath | EVP & CFO & Enterprise Technol | 7,837 | $540.50 | $122.3B | -42.80% | +0.25% | $4.2M | -4.69% | 10b5-1 | Trim |
| Dec 10, 2024 | Sell | ISRG | Jamie Samath | CFO and Head of Business Techn | 540 | $403.59 | $122.3B | -42.80% | +0.25% | $217.9K | +0.00% | 10b5-1 | Trim |
| Nov 29, 2024 | Sell | ISRG | Jamie Samath | CFO and Head of Business Techn | 376 | $394.31 | $122.3B | -42.80% | +0.25% | $148.3K | +0.00% | 10b5-1 | Trim |
| Nov 29, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 752 | $394.31 | $122.3B | -42.80% | +0.25% | $296.5K | +0.00% | 10b5-1 | Trim |
| Nov 26, 2024 | Sell | ISRG | Jamie Samath | CFO and Head of Business Techn | 216 | $419.28 | $122.3B | -42.80% | +0.25% | $90.6K | +0.00% | 10b5-1 | Trim |
| Nov 26, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 792 | $419.28 | $122.3B | -42.80% | +0.25% | $332.1K | +0.00% | 10b5-1 | Trim |
| Nov 22, 2024 | Sell | ISRG | David J. Rosa | President | 915 | $547.87 | $122.3B | -42.80% | +0.25% | $501.3K | -0.43% | — | Trim |
| Nov 12, 2024 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 26,932 | $366.67 | $122.3B | -42.80% | +0.25% | $9.9M | +0.00% | 10b5-1 | Trim |
| Nov 11, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 478 | $403.54 | $122.3B | -42.80% | +0.25% | $192.9K | +0.00% | 10b5-1 | Trim |
| Nov 8, 2024 | Sell | ISRG | Jamie Samath | — | 46,344 | $385.28 | $122.3B | -42.80% | +0.25% | $17.9M | +0.00% | 10b5-1 | Trim |
| Nov 5, 2024 | Sell | ISRG | David J. Rosa | President | 3,960 | $515.17 | $122.3B | -42.80% | +0.25% | $2.0M | -0.92% | — | Trim |
| Oct 30, 2024 | Sell | ISRG | Gary S Guthart | CEO | 50,791 | $287.03 | $122.3B | -42.80% | +0.25% | $14.6M | -0.37% | 10b5-1 | Trim |
| Oct 25, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 44 | $513.83 | $122.3B | -42.80% | +0.25% | $22.6K | -10.09% | 10b5-1 | Trim |
| Oct 25, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 3,568 | $392.94 | $122.3B | -42.80% | +0.25% | $1.4M | +0.00% | 10b5-1 | Trim |
| Oct 22, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 4,278 | $299.35 | $122.3B | -42.80% | +0.25% | $1.3M | -1.88% | 10b5-1 | Trim |
| Oct 22, 2024 | Sell | ISRG | Brian Edward Miller | EVP & Chief Digital Officer | 2,553 | $515.00 | $122.3B | -42.80% | +0.25% | $1.3M | -26.54% | 10b5-1 | Trim |
| Oct 10, 2024 | Sell | ISRG | Gary Loeb | General Counsel | 1,178 | $490.38 | $122.3B | -42.80% | +0.25% | $577.7K | -12.49% | — | Trim |
| Sep 10, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 476 | $372.27 | $122.3B | -42.80% | +0.25% | $177.2K | +0.00% | 10b5-1 | Trim |
| Sep 9, 2024 | Sell | ISRG | Gary Loeb | General Counsel | 300 | $475.00 | $122.3B | -42.80% | +0.25% | $142.5K | -15.83% | 10b5-1 | Trim |
| Aug 31, 2024 | Sell | ISRG | Marshall Mohr | Executive VP Global Business S | 1,698 | $492.63 | $122.3B | -42.80% | +0.25% | $836.5K | -50.72% | — | Trim |
| Aug 28, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 752 | $366.09 | $122.3B | -42.80% | +0.25% | $275.3K | +0.00% | 10b5-1 | Trim |
| Aug 26, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 792 | $391.69 | $122.3B | -42.80% | +0.25% | $310.2K | +0.00% | 10b5-1 | Trim |
| Aug 23, 2024 | Sell | ISRG | Henry L Charlton | SVP & Chief Commercial and Mkt | 60,001 | $373.35 | $122.3B | -42.80% | +0.25% | $22.4M | -3.79% | 10b5-1 | Trim |
| Aug 12, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 480 | $365.89 | $122.3B | -42.80% | +0.25% | $175.6K | +0.00% | 10b5-1 | Trim |
| Jul 30, 2024 | Sell | ISRG | Gary S Guthart | CEO | 68,528 | $220.54 | $122.3B | -42.80% | +0.25% | $15.1M | -1.38% | 10b5-1 | Trim |
| Jul 26, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 3,578 | $356.59 | $122.3B | -42.80% | +0.25% | $1.3M | +0.00% | 10b5-1 | Trim |
| Jul 23, 2024 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 5,636 | $318.06 | $122.3B | -42.80% | +0.25% | $1.8M | +0.00% | 10b5-1 | Trim |
| Jun 10, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 478 | $341.74 | $122.3B | -42.80% | +0.25% | $163.3K | +0.00% | 10b5-1 | Trim |
| Jun 10, 2024 | Sell | ISRG | David J. Rosa | President | 689 | $417.61 | $122.3B | -42.80% | +0.25% | $287.7K | -0.31% | — | Trim |
| May 28, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 1,544 | $338.09 | $122.3B | -42.80% | +0.25% | $522.0K | +0.00% | 10b5-1 | Trim |
| May 17, 2024 | Sell | ISRG | David J. Rosa | President | 2,507 | $398.82 | $122.3B | -42.80% | +0.25% | $999.8K | -1.15% | — | Trim |
| May 16, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 238 | $397.73 | $122.3B | -42.80% | +0.25% | $94.7K | -26.71% | 10b5-1 | Trim |
| May 16, 2024 | Sell | ISRG | Brian Edward Miller | EVP & Chief Digital Officer | 2,553 | $400.00 | $122.3B | -42.80% | +0.25% | $1.0M | -20.97% | 10b5-1 | Trim |
| May 13, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 525 | $385.74 | $122.3B | -42.80% | +0.25% | $202.5K | -19.82% | 10b5-1 | Trim |
| May 10, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 1,019 | $340.80 | $122.3B | -42.80% | +0.25% | $347.3K | -0.68% | 10b5-1 | Trim |
| Apr 26, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 3,748 | $319.66 | $122.3B | -42.80% | +0.25% | $1.2M | +0.00% | 10b5-1 | Trim |
| Apr 23, 2024 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 10,636 | $275.46 | $122.3B | -42.80% | +0.25% | $2.9M | +0.00% | 10b5-1 | Trim |
| Mar 15, 2024 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 6,265 | $331.07 | $122.3B | -42.80% | +0.25% | $2.1M | -61.53% | 10b5-1 | Trim |
| Mar 8, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 392 | $391.09 | $122.3B | -42.80% | +0.25% | $153.3K | -14.50% | 10b5-1 | Trim |
| Mar 8, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 35,682 | $352.68 | $122.3B | -42.80% | +0.25% | $12.6M | -1.87% | 10b5-1 | Trim |
| Mar 5, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 588 | $393.35 | $122.3B | -42.80% | +0.25% | $231.3K | -10.64% | 10b5-1 | Trim |
| Mar 1, 2024 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 1,605 | $383.48 | $122.3B | -42.80% | +0.25% | $615.5K | -84.34% | 10b5-1 | Trim |
| Feb 29, 2024 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 470 | $386.59 | $122.3B | -42.80% | +0.25% | $181.7K | -5.25% | — | Trim |
| Feb 29, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 935 | $386.59 | $122.3B | -42.80% | +0.25% | $361.5K | -14.76% | — | Trim |
| Feb 29, 2024 | Sell | ISRG | Henry L Charlton | SVP & Chief Commercial and Mkt | 980 | $386.59 | $122.3B | -42.80% | +0.25% | $378.9K | -2.00% | — | Trim |
| Feb 29, 2024 | Sell | ISRG | Jamie Samath | Chief Financial Officer | 987 | $386.59 | $122.3B | -42.80% | +0.25% | $381.6K | -5.03% | — | Trim |
| Feb 29, 2024 | Sell | ISRG | Brian Edward Miller | EVP & Chief Digital Officer | 1,428 | $386.59 | $122.3B | -42.80% | +0.25% | $552.1K | -5.25% | — | Trim |
| Feb 29, 2024 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 1,651 | $386.59 | $122.3B | -42.80% | +0.25% | $638.3K | -26.00% | — | Trim |
| Feb 29, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 1,700 | $386.59 | $122.3B | -42.80% | +0.25% | $657.2K | -6.53% | — | Trim |
| Feb 29, 2024 | Sell | ISRG | David J. Rosa | President | 1,905 | $386.59 | $122.3B | -42.80% | +0.25% | $736.5K | -0.43% | — | Trim |
| Feb 29, 2024 | Sell | ISRG | Gary S Guthart | CEO | 3,230 | $386.59 | $122.3B | -42.80% | +0.25% | $1.2M | -8.56% | — | Trim |
| Feb 28, 2024 | Buy | ISRG | Marshall Mohr | Executive VP Global Business S | 240,251 | $253.94 | $122.3B | -42.80% | +0.25% | $61.0M | +2.40% | 10b5-1 | Trim |
| Feb 26, 2024 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 218 | $389.77 | $122.3B | -42.80% | +0.25% | $85.0K | -3.44% | — | Trim |
| Feb 26, 2024 | Sell | ISRG | Henry L Charlton | SVP & Chief Commercial and Mkt | 384 | $389.77 | $122.3B | -42.80% | +0.25% | $149.7K | -1.25% | — | Trim |
| Feb 26, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 434 | $389.77 | $122.3B | -42.80% | +0.25% | $169.2K | -4.87% | — | Trim |
| Feb 26, 2024 | Sell | ISRG | Jamie Samath | Chief Financial Officer | 459 | $389.77 | $122.3B | -42.80% | +0.25% | $178.9K | -2.68% | — | Trim |
| Feb 26, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 498 | $389.77 | $122.3B | -42.80% | +0.25% | $194.1K | -2.88% | — | Trim |
| Feb 26, 2024 | Sell | ISRG | Brian Edward Miller | EVP & Chief Digital Officer | 649 | $389.77 | $122.3B | -42.80% | +0.25% | $253.0K | -3.32% | — | Trim |
| Feb 26, 2024 | Sell | ISRG | David J. Rosa | President | 867 | $389.77 | $122.3B | -42.80% | +0.25% | $337.9K | -0.37% | — | Trim |
| Feb 26, 2024 | Sell | ISRG | Marshall Mohr | Executive VP Global Business S | 867 | $389.77 | $122.3B | -42.80% | +0.25% | $337.9K | -2.94% | — | Trim |
| Feb 26, 2024 | Sell | ISRG | Gary S Guthart | CEO | 1,536 | $389.77 | $122.3B | -42.80% | +0.25% | $598.7K | -4.19% | — | Trim |
| Feb 26, 2024 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 1,710 | $388.14 | $122.3B | -42.80% | +0.25% | $663.7K | -12.20% | 10b5-1 | Trim |
| Feb 14, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 92 | $380.10 | $122.3B | -42.80% | +0.25% | $35.0K | -3.98% | 10b5-1 | Trim |
| Feb 12, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 60 | $380.80 | $122.3B | -42.80% | +0.25% | $22.8K | -3.55% | 10b5-1 | Trim |
| Feb 10, 2024 | Sell | ISRG | Gary Loeb | General Counsel | 129 | $388.22 | $122.3B | -42.80% | +0.25% | $50.1K | -4.35% | — | Trim |
| Feb 10, 2024 | Sell | ISRG | Fredrik Widman | VP Corporate Controller | 222 | $388.22 | $122.3B | -42.80% | +0.25% | $86.2K | -4.81% | — | Trim |
| Feb 10, 2024 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 316 | $388.22 | $122.3B | -42.80% | +0.25% | $122.7K | -2.82% | — | Trim |
| Feb 10, 2024 | Sell | ISRG | Henry L Charlton | SVP & Chief Commercial and Mkt | 338 | $388.22 | $122.3B | -42.80% | +0.25% | $131.2K | -1.36% | — | Trim |
| Feb 10, 2024 | Sell | ISRG | Jamie Samath | Chief Financial Officer | 401 | $388.22 | $122.3B | -42.80% | +0.25% | $155.7K | -3.80% | — | Trim |
| Feb 10, 2024 | Sell | ISRG | Mark Brosius | — | 425 | $388.22 | $122.3B | -42.80% | +0.25% | $165.0K | -11.18% | — | Trim |
| Feb 10, 2024 | Sell | ISRG | Brian Edward Miller | EVP & Chief Digital Officer | 487 | $388.22 | $122.3B | -42.80% | +0.25% | $189.1K | -3.42% | — | Trim |
| Feb 10, 2024 | Sell | ISRG | David J. Rosa | President | 729 | $388.22 | $122.3B | -42.80% | +0.25% | $283.0K | -0.33% | — | Trim |
| Feb 10, 2024 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 838 | $387.00 | $122.3B | -42.80% | +0.25% | $324.3K | -18.92% | 10b5-1 | Trim |
| Feb 10, 2024 | Sell | ISRG | Marshall Mohr | Executive VP Global Business S | 1,085 | $388.22 | $122.3B | -42.80% | +0.25% | $421.2K | -3.62% | — | Trim |
| Feb 10, 2024 | Sell | ISRG | Gary S Guthart | CEO | 1,335 | $388.22 | $122.3B | -42.80% | +0.25% | $518.3K | -6.69% | — | Trim |
| Feb 7, 2024 | Buy | ISRG | David J. Rosa | President | 221,560 | $175.10 | $122.3B | -42.80% | +0.25% | $38.8M | +3.17% | 10b5-1 | Trim |
| Feb 1, 2024 | Sell | ISRG | Mark Brosius | SVP & Chief Mfg and Supply Cha | 39 | $378.41 | $122.3B | -42.80% | +0.25% | $14.8K | -8.01% | 10b5-1 | Trim |
| Jan 29, 2024 | Buy | ISRG | Gary S Guthart | CEO | 63,035 | $201.90 | $122.3B | -42.80% | +0.25% | $12.7M | +4.78% | 10b5-1 | Trim |
| Jan 26, 2024 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 8,636 | $274.91 | $122.3B | -42.80% | +0.25% | $2.4M | +0.00% | 10b5-1 | Trim |
| Dec 13, 2023 | Sell | ISRG | David J. Rosa | President | 1,572 | $328.96 | $122.3B | -42.80% | +0.25% | $517.1K | -1.01% | — | Trim |
| Nov 16, 2023 | Sell | ISRG | Myriam Curet | EVP & Chief Medical Officer | 17,638 | $236.51 | $122.3B | -42.80% | +0.25% | $4.2M | +0.00% | 10b5-1 | Trim |
| Nov 14, 2023 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 1,734 | $267.29 | $122.3B | -42.80% | +0.25% | $463.5K | +0.00% | 10b5-1 | Trim |
| Oct 26, 2023 | Buy | ISRG | Gary S Guthart | CEO | 66,095 | $153.37 | $122.3B | -42.80% | +0.25% | $10.1M | +1.06% | 10b5-1 | Trim |
| Oct 24, 2023 | Sell | ISRG | Robert Desantis | EVP & Chief Strategy & Corp Op | 2,220 | $233.80 | $122.3B | -42.80% | +0.25% | $519.0K | +0.00% | 10b5-1 | Trim |
| Oct 10, 2023 | Sell | ISRG | Gary Loeb | General Counsel | 904 | $297.83 | $122.3B | -42.80% | +0.25% | $269.2K | -8.65% | — | Trim |